Proteasome Dysfunction Mediates Obesity-Induced Endoplasmic Reticulum Stress and Insulin Resistance in the Liver
暂无分享,去创建一个
S. Kaneko | Miyuki Yamamoto | Keiji Tanaka | Hiroaki Takayama | H. Misu | F. Lan | T. Takamura | Kaito Iwayama | S. Murata | Hiroto Hayashi | T. Ota | S. Iseki | Kazuhide Ishikura | Yuki Kita | Y. Takeshita | Toshiki Otoda | Seiichiro Kurita | Ken-ichiro Kato | Masafumi Uno | Takehiro Kanamori | Takashi Takeda | Akihiro Kikuchi | Kunpei Tokuyama | K. R. Shima | Tsuguhito Ota | K. Tokuyama
[1] C. Takayama,et al. Brown Rice and Its Component, γ-Oryzanol, Attenuate the Preference for High-Fat Diet by Decreasing Hypothalamic Endoplasmic Reticulum Stress in Mice , 2012, Diabetes.
[2] N. Danial,et al. Polysome Profiling in Liver Identifies Dynamic Regulation of Endoplasmic Reticulum Translatome by Obesity and Fasting , 2012, PLoS genetics.
[3] Y. Kido,et al. Endoplasmic Reticulum Stress Inhibits STAT3-Dependent Suppression of Hepatic Gluconeogenesis via Dephosphorylation and Deacetylation , 2011, Diabetes.
[4] J. Li,et al. Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. , 2011, The Journal of clinical investigation.
[5] Lee H. Dicker,et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity , 2011, Nature.
[6] M. White,et al. Regulation of glucose homeostasis through a XBP-1–FoxO1 interaction , 2011, Nature Medicine.
[7] Xuejun Wang,et al. Enhancement of proteasome function by PA28α overexpression protects against oxidative stress , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] G. Lewis,et al. Sodium Phenylbutyrate, a Drug With Known Capacity to Reduce Endoplasmic Reticulum Stress, Partially Alleviates Lipid-Induced Insulin Resistance and β-Cell Dysfunction in Humans , 2011, Diabetes.
[9] M. Honda,et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. , 2010, Cell metabolism.
[10] R. Rizza,et al. β-Cell Dysfunctional ERAD/Ubiquitin/Proteasome System in Type 2 Diabetes Mediated by Islet Amyloid Polypeptide–Induced UCH-L1 Deficiency , 2010, Diabetes.
[11] P. Kloetzel,et al. Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress , 2010, Cell.
[12] Ping Li,et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. , 2010, Cell metabolism.
[13] H. Hammes,et al. Hyperglycemia Impairs Proteasome Function by Methylglyoxal , 2009, Diabetes.
[14] M. Correia,et al. Hepatic CYP3A Suppression by High Concentrations of Proteasomal Inhibitors: A Consequence of Endoplasmic Reticulum (ER) Stress Induction, Activation of RNA-Dependent Protein Kinase-Like ER-Bound Eukaryotic Initiation Factor 2α (eIF2α)-Kinase (PERK) and General Control Nonderepressible-2 eIF2α Kinase , 2009, Molecular Pharmacology.
[15] F. Hamel. Preliminary report: inhibition of cellular proteasome activity by free fatty acids. , 2009, Metabolism: clinical and experimental.
[16] Shuichi Kaneko,et al. Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria , 2009, Journal of Biological Chemistry.
[17] S. Kaneko,et al. The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis. , 2009, Biochemical and biophysical research communications.
[18] M. Myers,et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. , 2009, Cell metabolism.
[19] M. Katze,et al. UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. , 2008, Developmental cell.
[20] M. Honda,et al. Obesity Upregulates Genes Involved in Oxidative Phosphorylation in Livers of Diabetic Patients , 2008, Obesity.
[21] M. Honda,et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. , 2008, Metabolism: clinical and experimental.
[22] L. Glimcher,et al. Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1 , 2008, Science.
[23] J. Goldstein,et al. Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.
[24] H. Ginsberg,et al. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. , 2008, The Journal of clinical investigation.
[25] James M. Roberts,et al. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. , 2007, Molecular cell.
[26] M. Honda,et al. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes , 2007, Diabetologia.
[27] Peter Walter,et al. Autophagy Counterbalances Endoplasmic Reticulum Expansion during the Unfolded Protein Response , 2006, PLoS biology.
[28] W. Mitch,et al. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. , 2006, Endocrinology.
[29] E. Yilmaz,et al. Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes , 2006, Science.
[30] S. Seino,et al. Essential Role of Ubiquitin-Proteasome System in Normal Regulation of Insulin Secretion* , 2006, Journal of Biological Chemistry.
[31] K. Wellen,et al. Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.
[32] D. Tindall,et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] H. Kaneto,et al. Involvement of Endoplasmic Reticulum Stress in Insulin Resistance and Diabetes* , 2005, Journal of Biological Chemistry.
[34] L. Glimcher,et al. Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.
[35] Hao Jiang,et al. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] N. Osna,et al. Peroxynitrite alters the catalytic activity of rodent liver proteasome in vitro and in vivo , 2004, Hepatology.
[37] P. Kloetzel. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII , 2004, Nature Immunology.
[38] M. Honda,et al. Genes for systemic vascular complications are differentially expressed in the livers of Type 2 diabetic patients , 2004, Diabetologia.
[39] P. Petronini,et al. Proteasome inhibition increases HuR level, restores heat-inducible HSP72 expression and thermotolerance in WI-38 senescent human fibroblasts , 2004, Experimental Gerontology.
[40] Hitomi Matsuzaki,et al. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[41] X. Wang,et al. Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.
[42] Xiaohua Shen,et al. The unfolded protein response in nutrient sensing and differentiation , 2002, Nature Reviews Molecular Cell Biology.
[43] Tomoki Chiba,et al. Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β , 2001 .
[44] Minoru Yoshida,et al. Direct Demonstration of Rapid Degradation of Nuclear Sterol Regulatory Element-binding Proteins by the Ubiquitin-Proteasome Pathway* , 2001, The Journal of Biological Chemistry.
[45] P. Kloetzel,et al. Kinetic evidences for facilitation of peptide channelling by the proteasome activator PA28. , 2000, European journal of biochemistry.
[46] Y. Murakami,et al. Hybrid Proteasomes , 2000, The Journal of Biological Chemistry.
[47] F. Urano,et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. , 2000, Science.
[48] M. Kasahara,et al. Growth Retardation in Mice Lacking the Proteasome Activator PA28γ* , 1999, The Journal of Biological Chemistry.
[49] A. Vitiello,et al. Impaired immunoproteasome assembly and immune responses in PA28-/- mice. , 1999, Science.
[50] M. Portero-Otín,et al. Diabetes induces an impairment in the proteolytic activity against oxidized proteins and a heterogeneous effect in nonenzymatic protein modifications in the cytosol of rat liver and kidney. , 1999, Diabetes.
[51] C. Slaughter,et al. The Proteasome, a Novel Protease Regulated by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.
[52] P. Henklein,et al. Expression and subcellular localization of mouse 20S proteasome activator complex PA28 , 1997, FEBS letters.
[53] J. Olefsky,et al. Stressed out about obesity and insulin resistance , 2006, Nature Medicine.
[54] F. Urano,et al. Transcriptional and translational control in the Mammalian unfolded protein response. , 2002, Annual review of cell and developmental biology.
[55] M. Kasahara,et al. Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. , 2001, The EMBO journal.
[56] Y. Murakami,et al. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. , 2000, The Journal of biological chemistry.
[57] W. Baumeister,et al. The 26S proteasome: a molecular machine designed for controlled proteolysis. , 1999, Annual review of biochemistry.